PRECISION RESEARCH PEPTIDES, SYNTHESIZED FOR INTEGRITY.

Metabolic Research

• Retatrutide (30mg): A next-generation triple-receptor agonist (GLP-1/GIP/glucagon) currently under investigation for its interactions with metabolic signalling pathways in controlled laboratory environments.
• Tirzepatide: A dual incretin receptor agonist studied for its effects on glucose homeostasis and appetite-regulation signalling within in vitro and preclinical research models.
• NAD+ (1000mg): An essential coenzyme examined in research settings for its role in DNA repair mechanisms, mitochondrial function, and cellular energy metabolism.
• MOTS-c (30mg): A mitochondrial-derived peptide under investigation for its role in metabolic regulation and cellular homeostasis signalling pathways.

Neuroscience Research

• Cerebrolysin (60mg): A neurotrophic peptide preparation studied in research contexts for its potential interactions with neuroprotective and neuroplasticity-related pathways.
• Selank (10mg): A synthetic anxiolytic peptide analogue studied for its modulation of dopamine and serotonin signalling in preclinical models.
• DSIP (10mg): Delta Sleep-Inducing Peptide — a naturally occurring neuromodulator investigated for its interactions with sleep-regulation and circadian rhythm pathways in laboratory research.

Peptide Bioregulator Research

• Epithalon (50mg): A synthetic tetrapeptide studied in research settings for its potential role in telomerase regulation and pineal gland function.
• Thymalin (10mg): A thymic bioregulator peptide under investigation for its interactions with immune-system signalling pathways in preclinical research models.
• SS-31 (50mg): A mitochondria-targeted peptide studied for its interactions with the inner mitochondrial membrane and oxidative stress signalling in laboratory environments.

Cellular & Mitochondrial Research

• Tesamorelin (20mg): A GHRH analogue investigated in research contexts for its interactions with growth hormone release pathways and metabolic signalling.
• IGF-1 LR3 (1mg): An extended half-life growth factor analogue studied for its interactions with insulin-like growth factor receptor signalling in preclinical models.
• KLOV (80mg): A specialised peptide studied in laboratory settings for its potential roles in cellular signalling and mitochondrial function pathways.

Endocrine Research

• Kisspeptin-10: A neuropeptide studied for its interactions with GnRH-release signalling and hypothalamic–pituitary–gonadal axis regulation in preclinical research.